View this e-Edition online!
Letter from the Publisher
Jonathan Collin, MD
Treat Outside the Box
by Leigh Erin Connealy, MD
Dr. Connealy, an integrative cancer expert, utilizes low-dose insulin-potentiated chemotherapy, as well as genetic testing to determine exact effective therapies, both alternative and chemotherapy. She discusses the evolution of her approach, and what sets her clinic apart from traditional facilities.
Chemosensitivity Testing: Customizing Cancer Treatment
by Mary Budinger
Most patients are subjected to a standardized approach to chemotherapy; it is not routine to test a sample to determine which drugs would be most effective. But could tests produce better outcomes? This question was a focus of the Best Answer for Cancer's 11th Annual International IPT/IPTLD Integrative Cancer Care conference.
Hyperthermia: A Treatment Possibility for Prostate Cancer
by Friedrich R. Douwes, MD
Guidelines suggest monitoring the patient through a "wait-and-watch" approach. But as many men psychologically cannot tolerate this after they have been diagnosed, there is considerable interest in finding an alternative with relatively few side effects.
Fever Therapy in Oncology
by Gurdev Parmar, ND, FABNO
The author, who has provided nearly 200 hyperthermia treatments for cancer, writes about the experience both from the doctor's perspective and the patient's, as he includes his own experience undergoing a session.
Naturopathic Oncology: A Necessity for Every Patient with Cancer
by Veronica A. Stevens, ND, FABNO
The oncology community has long held that the use of "natural medicines" during conventional cancer treatment is contraindicated. There is an unmet need for safe and effective natural therapies – which can be met by naturopathic oncologists, as care providers who bringing an expanded view and balance to conventional care.
Naturopathic Co-Management of Patients Receiving Adjuvant Endocrine Therapy for Breast Cancer
by Stacy Dunn, ND, MSOM, FABNO
HR positive breast cancer exhibits a favorable response to antihormone therapies, but patient compliance is often poor due to side effects, and late recurrence is common due to developed resistance. Dr. Dunn explains the key role for naturopathic physicians in managing patients on these therapies through the mitigation of side effects and toxicities, often resulting in improved treatment efficacy and disease outcomes.
Aspirin for Treating Breast Cancer
by Jacob Schor, ND, FABNO
Is aspirin a natural medicine or is it a drug? Whichever it is, at least four recent major papers have reported on its benefits in preventing and treating breast cancer. Schor considers that its use might be congruent with naturopathic principles, pointing out that aspirin may not be as "unnatural" as people think.
Current Themes in Integrative Cancer Research and Cancer Care
An Interview with Leanna Standish, PhD, ND, MS, LAc, FABNO
Dr. Standish discusses the emerging field of naturopathic oncology within integrative oncology, her work as medical director of the Bastyr Integrative Oncology Research Center (BIORC) and with the Oncomycology Translational Research Center, and exploratory work such as distance healing and South American psychotropics.
Ursolic Acid: A Novel Anti-Muscle-Wasting, Anticancer, and Antidiabetic Compound
by Mark A. Brudnak and Eric J. Baer
Muscle loss is associated with many diseases, as well as with weight loss. Ursolic acid provides a way for muscle mass to be not just maintained but actually increased while reducing adiposity. UA has also been shown to inhibit proliferation and induce apoptosis in cancer, protect diabetic mice from monocyte dysfunction, inhibit invasion and migration of human lung cancer cells, and be antiangiogenic against human liver cancer cells.
Salicinium: A New Nontoxic Cancer Cotreatment
by Robert A. Eslinger, DO, HMD
Since starting to use Salicinium, the Reno Integrative Medical Center has seen a dramatic improvement in patient treatment outcomes. Medical director Dr. Eslinger describes the mechanism of action of this natural plant extract, offering a study and patient examples.
Why a True Cancer Cure Will Not Exist within the Current Paradigm of Traditional Medical Treatment
by Thomas A. Braun, RPh
The pharmaceutical approach to curing cancer will never address the root cause of the problem. The author looks instead at the relevant lifestyle issues, including a specific nutrient deficiency.
Healthy Dissent: Resisting Attacks on Alternative Medicine
by Brian Martin, PhD
Challenging orthodox opinion has seldom been easy, and health and medicine are prime areas for suppression. To illustrate the dangers and give suggestions about how to defend against them, a case study is presented: the systematic attack on a group critical of vaccination.
The Cayce Cure For Cancer
by Phil Thomas
In his readings, psychic Edgar Cayce referred to ash and ultraviolet light as promising approaches to cancer. The author, who has been exploring this subject for decades, shares his experiences.
Pathways to Healing
Affordable Care Act Offers Incentives for Prevention
War on Cancer
Harvard Study: Antioxidants Safe for Breast Cancer Patients
Ralph Moss, PhD
An Anti-Aging Perspective on Cancer Prevention
Ronald Klatz, MD, DO, and Robert Goldman, MD, PhD, DO
Literature Review & Commentary
Alan R. Gaby, MD
The Massive Underutilization of Thyroid Hormone Replacement Therapy: Part 1
Michael Gerber, MD, HMD
Environmental Medicine Update
Copper Chelation and Cancer
Marianne Marchese, ND
Rotator Cuff Shoulder Injuries
Peter A. Fields, MD, DC
The Next Course: Because Cancer Prevention Is Priceless
Ingrid Kohlstadt, MD, MPH
Women's Health Update
Breast Implants, Loop Excisions, and 3D Mammography
Tori Hudson, ND
Chelation Study Shows Benefit but Stirs Controversy
Alan Gaby, MD
In the News
Dr. Ron Hunninghake of the Riordan Clinic inducted into the 2013 Orthomolecular Medicine Hall of Fame
New Study Identifies the Optimal Dose of Intravenous Vitamin C for Future Anticancer Clinical Trials
ApothéCure Explains Closure
Antioxidants Prevent Cancer and Some May Even Cure It
Standard Process Microbiologist Joins International Analytical Association
Report on the Proceedings of a Summit on New Directions for Chelation Therapy
Letters to the Editor
Barnes's Monumental Research Is Ignored
by Mark Mincolla, PhD
review by Katherine Duff
Beyond the Magic Bullet
by Raymond Chang, MD
review by Jonathan Collin, MD
. . . the regular features, commentary and opinions
we can count on each month from our